- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12:10 | Novartis pumps up community health footprint to tackle heart disease and cancer | ||
| Do | Vanda initiates study of motion sickness drug Nereus on GLP-1 users | ||
| Do | Garda snaps up Assertio and chemo infection treatment Rolvedon in $125M deal | ||
| Do | AbbVie challenges 'outdated' 340B drug discount program guidance in new lawsuit | ||
| Do | RFK Jr. launching health podcast to expose 'hypocrisy' and 'corruption' | ||
| Mi | Steven Ubl set to depart after more than a decade as CEO of PhRMA | ||
| Mi | Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant | ||
| Mi | J&J's Tremfya retakes TV drug ad spending crown from AbbVie | ||
| Mi | Pfizer walks away from 'underutilized' office space in South San Francisco, transitions employees to remote roles | ||
| Mi | Biogen settles investor lawsuit over its messaging on failed Alzheimer's drug Aduhelm | ||
| Mi | Amgen CEO netted $24.7M pay package in '25 as company's upward trajectory continued | ||
| Mi | Cognito Therapeutics moves to drop 'dementia' from its comms, scientific materials | ||
| Mi | Invivyd launches 'Antibodies for Any Body' campaign with Olympic skier Lindsey Vonn | ||
| Mi | Insmed terminates development of Brinsupri in another indication after midstage HS flop | ||
| Di | With Gardasil demand shortfall in China, Merck and Zhifei adjust their partnership | ||
| Di | Vertex taps Halozyme and its recently acquired Elektrofi tech in $15M drug delivery deal | ||
| Di | FDA seeks legislative teeth to bite back against misleading DTC drug ads | ||
| Mo | ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols | ||
| Mo | Insulet's Omnipod takes Type 2 diabetes representation to the TV screen in 'Scrubs' revival | ||
| Mo | Neurocrine, eying 'blockbuster in the making,' strikes its largest-ever M&A deal with $2.9B Soleno buyout | ||
| Mo | Amgen scores with trial of on-body injected version of Tepezza in thyroid eye disease | ||
| Mo | VML Health urges marketers to shift from lifespan to 'joyspan' as patient goals evolve | ||
| Mo | Eli Lilly takes the court with 150th anniversary campaign to catch Final Four crowd | ||
| 03.04. | An update on the pharma industry's reshoring effort | ||
| 02.04. | Trump slaps 100% duties on imported drugs but leaves plenty of exceptions |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.